Apple Signals Product Price Hikes Amid Rising Memory Chip Costs 
Samsung Electronics Stock Surges on Report of Massive $59 Billion Share Buyback Plan 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence 
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
Chinese Social Media Giant Xiaohongshu Eyes Hong Kong IPO at Over $70 Billion Valuation 
Today’s space race could turn fatal if we don’t agree on new rules 
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular 
Fans of wearable devices in more countries might start considering using the Samsung Galaxy Watch 3 or Watch Active 2 as their vital health monitoring features will be available soon. The tech company acquired the necessary permissions for its Health Monitor app to function in a total of 31 countries.
Samsung’s advanced health monitoring services cleared for use in more countries
The Samsung Galaxy Watch 3 and Watch Active 2 are equipped with sensors that allow them to monitor a user’s blood pressure and function with electrocardiogram (ECG) tracking. However, reading this data would require the Samsung Health Monitor app.
Like other health and medical products, the Samsung Health Monitor app needed to be approved in different countries following different regulations. It explains why tech features of this nature typically launch in limited territories. However, this changes for Samsung after the company acquired CE-marking last December for the software product allowing it to launch in European countries.
Samsung Galaxy Watch 3 and Watch Active 2 users Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, and the United Kingdom will soon be able to use the said app for BP and ECG tracking. The app is also launching in Chile, Indonesia, and the UAE making it available in 31 countries after only being accessible in South Korea.
Once the Samsung Health Monitor app goes live in the said countries, Samsung Galaxy Watch 3 and Watch Active 2 have to be updated to their latest versions. Doing so will automatically install the app on the wearable devices. Updates can be initiated through the Galaxy Wearable app via a paired Galaxy smartphone.
Samsung Galaxy Watch 4 rumored to launch with blood sugar level sensor
Having a blood pressure and ECG monitor on people’s wrists through devices like Samsung Galaxy Watch 3 and Watch Active 2 is already a notable technological development. But the company is reportedly looking to add another essential medical tracker in its upcoming Galaxy Watch 4.
ET News reported that Samsung is planning to launch the Galaxy Watch 4 with blood sugar level tracking this year. It is expected to use optic sensors that would allow measure blood glucose levels without blood sampling.
